Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1996
12/19/1996WO1996040242A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/19/1996WO1996040241A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996WO1996040239A1 Modified meningococcal polysaccharide conjugate vaccines
12/19/1996WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/19/1996WO1996040237A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
12/19/1996WO1996040236A1 Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof
12/19/1996WO1996040235A1 Method to use superantigens to target subpopulations of t cells
12/19/1996WO1996040234A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040233A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040232A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
12/19/1996WO1996040231A1 Method for obtaining receptor agonist antibodies
12/19/1996WO1996040230A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996WO1996040229A1 Vaccines synthesized by transgenic plants
12/19/1996WO1996040228A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996WO1996040227A1 Tumor associated epitopes
12/19/1996WO1996040225A1 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
12/19/1996WO1996040219A1 Inhibin compositions and methods of enhancing production performance
12/19/1996WO1996040211A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996WO1996040200A1 Method for treating tumors with a toxin
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040198A1 Synthesis of asparagine-linked glycopeptides on a polymeric solid support
12/19/1996WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040176A1 Therapeutic uses of monoclonal antibody ta99 in combination with interleukin-2 and/or lymphokine activated killer cells
12/19/1996WO1996040174A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996WO1996040173A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996WO1996040077A2 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
12/19/1996WO1996040069A1 System and method for producing drug-loaded microparticles
12/19/1996WO1996040066A1 A METHOD FOR ELICITING A Th1-SPECIFIC IMMUNE RESPONSE
12/19/1996WO1996040065A1 Improved liposomal formulation
12/19/1996WO1996040063A1 Process for making liposome preparation
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039862A1 High moisture nutrient formulation for poultry and other animals
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996031237A3 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
12/19/1996DE19521705A1 Immunogenes Konstrukt, Verfahren zu dessen Herstellung und Verwendung als Vakzine An immunogenic construct, a process for its preparation and use as a vaccine
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2288401A1 Icam-4 materials and methods
12/19/1996CA2252811A1 Polyphosphazene polyelectrolyte immunoadjuvants
12/19/1996CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2224174A1 Method for obtaining receptor agonist antibodies
12/19/1996CA2224172A1 Use of gram-positive bacteria to express recombinant proteins
12/19/1996CA2224160A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996CA2223993A1 Method for treating tumors with a toxin
12/19/1996CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223889A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996CA2223885A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996CA2223808A1 Process for making liposome preparation
12/19/1996CA2223737A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996CA2223714A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/19/1996CA2223610A1 Nucleic acid respiratory syncytial virus vaccines
12/19/1996CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223599A1 Hiv-1 prophylactic composition and method
12/19/1996CA2223591A1 Recombinant fowlpox viruses and uses thereof
12/19/1996CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system
12/19/1996CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
12/19/1996CA2223303A1 Treatment of t cell mediated autoimmune disorders
12/19/1996CA2223182A1 Expression system for non-secretor genes
12/19/1996CA2223077A1 Thrombin receptor homolog
12/19/1996CA2223041A1 Immunological combination compositions and methods
12/19/1996CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996CA2222999A1 Novel ctla4/cd28 ligands and uses therefor
12/19/1996CA2222947A1 Inhibin compositions and methods of enhancing production performance
12/19/1996CA2222761A1 Recombinant bacterial system with environmentally limited viability
12/19/1996CA2222551A1 Tumor associated epitopes
12/19/1996CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996CA2221646A1 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus
12/19/1996CA2221511A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/19/1996CA2221480A1 Mutants of streptococcal toxin a and methods of use
12/19/1996CA2221313A1 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
12/19/1996CA2221310A1 Improved liposomal formulation
12/19/1996CA2220952A1 Anti-allergy bispecific molecules
12/19/1996CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996CA2219457A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
12/19/1996CA2196691A1 Macrophage derived chemokine and chemokine analogs
12/18/1996EP0748867A1 Marek's disease vaccine
12/18/1996EP0748816A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748815A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748447A1 Assay for the diagnosis of schizophrenia
12/18/1996EP0748375A1 Selective virus culture
12/18/1996EP0748224A1 Antibacterial agent containing tea extract or active fraction thereof and beta-lactam antibiotic
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
1 ... 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 ... 1823